What is Multiple Sclerosis?
Multiple Sclerosis is a neurodegenerative disease that can be benign or malignant and lead to major disability. The disease is triggered by various causative environmental factors predominantly in a person with genetic propensity. Currently, a prescription of steroids is generally a part of the rehabilitative solution which can be very harmful in long-term use causing various life altering side effects. In cases of multiple sclerosis, the myelin sheath that surrounds the nerve fibers is severely damaged and neurons are exposed which halts the transmission process in the central nervous system.
Treatment of Multiple Sclerosis at Cellebration Life Sciences, Inc.
Stem cell treatments can address the challenges in disease progression by offering the most noninvasive treatment available to limit the cells damage and reduce the symptoms. The stem cells are capable of differentiation in various cell lines and can work in synchrony with tissue specific cells for regeneration and recovery. These cells are administered through one of two methods after a considerable analysis of the patient’s unique history and medical professional’s advice.
- Intrathecal Administration:- In this mode, cells are infused in the cerebrospinal fluid through subarachnoid spaces of the spinal cord.
- Intravenous Administration:- In this mode, cells are infused into the peripheral veins to increase blood volume in the system and ensure that a maximum number of cells are reaching the targeted area.
These infused cells reach the site and through paracrine effects. They then differentiate into neurons and help revive the damaged ones to restore proper function. Thus, with stem cell-based therapies it is now possible to obtain noticeable improvements and arrest progression in patients with Multiple Sclerosis.
